Prof Dr Michael Roth (PhD), Research Group Leader Pulmonary Cell Research at the University Hospital Basel in Switzerland explains the extent to which asthma and COPD (smoker’s lung) are the most prevalent chronic inflammatory diseases of the lung, globally

Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explores the issue of severe asthma and how our understanding of it is evolving

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies.
Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...

Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to do
The Finnish Allergy Programme 2008-2018 was initiated to reduce the burden of allergy in both patients and society. The set-up of the programme was unique....

Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease
Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...

Roberta Savli from EFA provides insight into allergic rhinitis
Rhinitis is a very common disorder, far more than just sneezing a couple of days in the year. Allergic rhinitis is a serious chronic respiratory disease that reduces patients’ quality of life and their productivity at work and at school. Despite...

Open Access Government produces compelling and informative products for a wide audience. Our dedicated team have many years’ experience and are committed to delivering up-to-date analysis, news and exclusive features for a public and private sector readership.